9,10-dimethyl-1,2-benzanthracene has been researched along with Chloasma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, K; Dobson, RL; Palotay, JL; Pinto, JS | 1 |
| Baron, J; Bogh, LD; Folberg, R; Reeves, RD; Stevens, RH | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Chloasma
| Article | Year |
|---|---|
Carcinogen-induced cutaneous neoplasms in nonhuman primates.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Benzene Derivatives; Carcinoma, Basal Cell; Cocarcinogenesis; Galago; Haplorhini; Macaca mulatta; Male; Melanosis; Neoplasms, Experimental; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Papilloma; Primates; Sarcoma; Skin Diseases; Skin Neoplasms; Time Factors; Ultraviolet Rays | 1976 |
Animal model of conjunctival primary acquired melanosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Conjunctival Diseases; Disease Models, Animal; Drug Administration Schedule; Melanins; Melanosis; Pigmentation; Rabbits; Time Factors | 1989 |